|
Index of reports
> Cases with Death (8)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Clolar (Clofarabine) where reactions include death. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Clolar side effects in female
Reported by a consumer/non-health professional from United States on 2012-04-25
Patient: female
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Clolar
Possible Clolar side effects in
Reported by a consumer/non-health professional from United States on 2012-04-09
Patient:
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Clolar
Possible Clolar side effects in
Reported by a pharmacist from United States on 2012-04-02
Patient:
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Clolar
Possible Clolar side effects in
Reported by a pharmacist from United States on 2012-03-30
Patient:
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Clolar
Possible Clolar side effects in
Reported by a physician from United States on 2012-03-30
Patient:
Reactions: Death, Fall
Adverse event resulted in: death
Drug(s) suspected as cause:
Clolar
Possible Clolar side effects in
Reported by a physician from United States on 2012-03-09
Patient:
Reactions: Death, Fall
Adverse event resulted in: death
Drug(s) suspected as cause:
Clolar
Possible Clolar side effects in 6 year old female
Reported by a physician from Argentina on 2011-10-17
Patient: 6 year old female
Reactions: Death, Sepsis, Haematotoxicity
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Clolar
Dosage: 40 mg/m2, qdx5 (cycle 1)
Indication: Acute Lymphocytic Leukaemia Recurrent
Start date: 2010-11-02
Cyclophosphamide
Dosage: unk (cycle 1)
Indication: Acute Lymphocytic Leukaemia Recurrent
Start date: 2010-11-02
Clolar
Dosage: 40 mg/m2, qdx5 (cycle 2)
Cyclophosphamide
Dosage: unk (cycle 2)
Etoposide
Dosage: unk (cycle 1)
Indication: Acute Lymphocytic Leukaemia Recurrent
Start date: 2010-11-02
Etoposide
Dosage: unk (cycle 2)
Possible Clolar side effects in 11 year old female
Reported by a physician from Colombia on 2011-10-11
Patient: 11 year old female, weighing 35.0 kg (77.0 pounds)
Reactions: Large Intestine Perforation, Neutropenic Colitis, Stomatitis, Anaemia, Febrile Neutropenia, Pyrexia, Klebsiella Bacteraemia, Death, Thrombocytopenia, Sinusitis, Leukopenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Clolar
Dosage: 60 mg (52 mg/m2), qdx5 (cycle 1)
Indication: Acute Lymphocytic Leukaemia
Clolar
Dosage: 60 mg (52 mg/m2), qdx5 (cycle 2)
Other drugs received by patient: Hydrocortisone; Ondansetron; Acetaminophen; Hydroxyzine; Ranitidine
|
